Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen C Rubin

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Gynecologic Oncology|December 21, 2010
Clinical predictors of bevacizumab-associated gastrointestinal perforationJanos L Tanyi, Georgia McCann, Andrea R Hagemann, et al.
Cancer Nursing|December 19, 2014
Resilience, Positive Coping, and Quality of Life Among Women Newly Diagnosed With Gynecological CancersSharon L Manne, Shannon Myers-Virtue, Deborah Kashy, et al.
Blood|September 11, 2004
Vascular leukocytes contribute to tumor vascularizationJose R Conejo-Garcia, Ronald J Buckanovich, Fabian Benencia, et al.
Cancer Biology & Therapy|January 22, 2005
RNA interference: a potential strategy for isoform-specific phosphatidylinositol 3-kinase targeted therapy in ovarian cancerLin Zhang, Nuo Yang, Shun Liang, et al.
Clinical Immunology (Orlando, Fla.)|March 14, 2002
Tumor-associated macrophages as a source of functional dendritic cells in ovarian cancer patientsChristina S Chu, Edward Y Woo, Alanna J Toll, et al.
Leukemia & Lymphoma|October 27, 2006
Primary lymphomas of the cervix and uterus: the University of Pennsylvania's experience and a review of the literatureNoelle V Frey, Jakub Svoboda, Charalambos Andreadis, et al.
The New England Journal of Medicine|December 14, 2004
Secondary surgical cytoreduction for advanced ovarian carcinomaPeter G Rose, Stacy Nerenstone, Mark F Brady, et al.
Psycho-Oncology|July 17, 2016
Group-based trajectory modeling of fear of disease recurrence among women recently diagnosed with gynecological cancersSharon L Manne, Shannon Myers-Virtue, David Kissane, et al.
Cancer Research|June 18, 2003
Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancerLin Zhang, Nuo Yang, Jin-Wan Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group StudyWilliam E Winter, G Larry Maxwell, Chunqiao Tian, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Gynecologic Oncology|December 21, 2010
Clinical predictors of bevacizumab-associated gastrointestinal perforationJanos L Tanyi, Georgia McCann, Andrea R Hagemann, et al.
Cancer Nursing|December 19, 2014
Resilience, Positive Coping, and Quality of Life Among Women Newly Diagnosed With Gynecological CancersSharon L Manne, Shannon Myers-Virtue, Deborah Kashy, et al.
Blood|September 11, 2004
Vascular leukocytes contribute to tumor vascularizationJose R Conejo-Garcia, Ronald J Buckanovich, Fabian Benencia, et al.
Cancer Biology & Therapy|January 22, 2005
RNA interference: a potential strategy for isoform-specific phosphatidylinositol 3-kinase targeted therapy in ovarian cancerLin Zhang, Nuo Yang, Shun Liang, et al.
Clinical Immunology (Orlando, Fla.)|March 14, 2002
Tumor-associated macrophages as a source of functional dendritic cells in ovarian cancer patientsChristina S Chu, Edward Y Woo, Alanna J Toll, et al.
Leukemia & Lymphoma|October 27, 2006
Primary lymphomas of the cervix and uterus: the University of Pennsylvania's experience and a review of the literatureNoelle V Frey, Jakub Svoboda, Charalambos Andreadis, et al.
The New England Journal of Medicine|December 14, 2004
Secondary surgical cytoreduction for advanced ovarian carcinomaPeter G Rose, Stacy Nerenstone, Mark F Brady, et al.
Psycho-Oncology|July 17, 2016
Group-based trajectory modeling of fear of disease recurrence among women recently diagnosed with gynecological cancersSharon L Manne, Shannon Myers-Virtue, David Kissane, et al.
Cancer Research|June 18, 2003
Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancerLin Zhang, Nuo Yang, Jin-Wan Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group StudyWilliam E Winter, G Larry Maxwell, Chunqiao Tian, et al.
Pageof 6